516 related articles for article (PubMed ID: 16857304)
1. [The skin overlying the sentinel lymph node: a full thickness skin graft donor site after local excision for cutaneous melanoma].
Chennoufi M; Guihard T; Lantieri L
Ann Chir Plast Esthet; 2007 Feb; 52(1):35-8. PubMed ID: 16857304
[TBL] [Abstract][Full Text] [Related]
2. Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
Lewis JM; Zager JS; Yu D; Pelaez D; Riker AI; Dessureault S; Cruse CW; Reintgen DS; Puleo CA; Sondak VK
Ann Surg Oncol; 2008 Jun; 15(6):1733-40. PubMed ID: 18379848
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
4. [Full thickness skin grafts obtained from the skin overlying sentinel nodes].
de Almirón AC; Serrano-Ortega S
Actas Dermosifiliogr; 2009 Nov; 100(9):780-4. PubMed ID: 19889299
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy site used as full thickness skin graft donor for cutaneous melanoma.
Dresel A; Kuhn JA; McCarty TM
Am J Surg; 2002 Aug; 184(2):176-8. PubMed ID: 12169366
[TBL] [Abstract][Full Text] [Related]
6. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
8. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Nathansohn N; Schachter J; Gutman H
Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
[TBL] [Abstract][Full Text] [Related]
9. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
12. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection.
Kretschmer L; Thoms KM; Peeters S; Haenssle H; Bertsch HP; Emmert S
Melanoma Res; 2008 Feb; 18(1):16-21. PubMed ID: 18227703
[TBL] [Abstract][Full Text] [Related]
13. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility and technical problems of sentinel node analysis in melanoma].
Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
[TBL] [Abstract][Full Text] [Related]
15. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.
van Poll D; Thompson JF; Colman MH; McKinnon JG; Saw RP; Stretch JR; Scolyer RA; Uren RF
Ann Surg Oncol; 2005 Aug; 12(8):597-608. PubMed ID: 16021534
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
Morris KT; Busam KJ; Bero S; Patel A; Brady MS
Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
19. [Surgical management of cutaneous malignant melanoma. Review].
Lavie A; Desouches C; Casanova D; Bardot J; Grob JJ; Legré R; Magalon G
Ann Chir Plast Esthet; 2007 Feb; 52(1):1-13. PubMed ID: 17030081
[TBL] [Abstract][Full Text] [Related]
20. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
